Brief: Aridis Pharmaceuticals - Got Written Notification From Nasdaq Indicating Failure To Satisfy A Continued Listing Rule
05/10/2022 12:04
Oct 5 (Reuters) - Aridis Pharmaceuticals Inc ARDS.O :
* ARIDIS PHARMACEUTICALS - ON SEPT 29 GOT WRITTEN
NOTIFICATION
FROM NASDAQ INDICATING FAILURE TO SATISFY A CONTINUED LISTING
RULE
Further company coverage: ARDS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aridis Pharmaceuticals
See all newsBrief: Aridis Pharmaceuticals Inc - On September 7 Nasdaq Announced That It Would Delist Common Stock Of Co
U.S. STOCKS ON THE MOVE-Pieris Pharma, Microsoft, Energy sector
U.S. STOCKS ON THE MOVE-Medtronic, Morgan Stanley, Bank of America
U.S. STOCKS ON THE MOVE-Teladoc Health, NVDIA, Chipotle
U.S. STOCKS ON THE MOVE-Pinterest, Sunrun, Tencent Music